For their proof of concept, they worked with the EGFR gene, which is central to the development of various types of cancer, including lung, brain and breast cancer. Platt and his team combined two ...

(A) Oncogene mutations were grouped together when they occurred within a given gene (e.g., 'KRAS' for all ... the mutation was grouped separately (e.g., 'EGFR_T790M' for the T790M mutation of ...

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...